Switch to:

Verrica Pharmaceuticals EV-to-EBIT

: -6.70 (As of Today)
View and export this data going back to 2018. Start your Free Trial

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Verrica Pharmaceuticals's Enterprise Value is $180.49 Mil. Verrica Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2019 was $-26.95 Mil. Therefore, Verrica Pharmaceuticals's EV-to-EBIT for today is -6.70.

NAS:VRCA' s EV-to-EBIT Range Over the Past 10 Years
Min: -210.91   Max: 0
Current: -6.71

-210.91
0
NAS:VRCA's EV-to-EBIT is ranked lower than
99.99% of the 263 Companies
in the Biotechnology industry.

( Industry Median: 19.12 vs. NAS:VRCA: -6.71 )

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Verrica Pharmaceuticals's Enterprise Value for the quarter that ended in Mar. 2019 was $185.43 Mil. Verrica Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2019 was $-26.95 Mil. Verrica Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2019 was -14.54%.


Verrica Pharmaceuticals EV-to-EBIT Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Verrica Pharmaceuticals Annual Data

Dec16 Dec17 Dec18
EV-to-EBIT 0.00 0.00 -5.75

Verrica Pharmaceuticals Quarterly Data

Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19
EV-to-EBIT Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -37.43 -19.83 -5.75 -6.88

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Verrica Pharmaceuticals EV-to-EBIT Distribution

* The bar in red indicates where Verrica Pharmaceuticals's EV-to-EBIT falls into.



Verrica Pharmaceuticals EV-to-EBIT Calculation

Verrica Pharmaceuticals's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=180.488/-26.953
=-6.70

Verrica Pharmaceuticals's current Enterprise Value is $180.49 Mil.
Verrica Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2019 was -6.112 (Jun. 2018 ) + -6.739 (Sep. 2018 ) + -6.076 (Dec. 2018 ) + -8.026 (Mar. 2019 ) = $-26.95 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Verrica Pharmaceuticals  (NAS:VRCA) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it consider the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Verrica Pharmaceuticals's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2019 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Mar. 2019 =EBIT / Enterprise Value (Q: Mar. 2019 )
=-26.953/185.43298
=-14.54 %

Verrica Pharmaceuticals's Enterprise Value for the quarter that ended in >Mar. 2019 was $185.43 Mil.
Verrica Pharmaceuticals's EBIT for the trailing twelve months (TTM) ended in Mar. 2019 was -6.112 (Jun. 2018 ) + -6.739 (Sep. 2018 ) + -6.076 (Dec. 2018 ) + -8.026 (Mar. 2019 ) = $-26.95 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Verrica Pharmaceuticals EV-to-EBIT Explanation


Verrica Pharmaceuticals EV-to-EBIT Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GF Chat

{{numOfNotice}}